Dr. Thomson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1152 E 200 N
American Fork, UT 84003Phone+1 801-772-0698Fax+1 801-772-0705
Summary
- I am a physician, board certified in Medical Oncology, Hematology, and Internal Medicine. I have a wide array of clinical interests: from breast cancer to malignant hematology, melanoma, lung and GI cancers, and benign hematology.
Education & Training
University of TennesseeFellowship, Hematology and Medical Oncology, 2018 - 2021
University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 2014 - 2017
University of Arizona College of MedicineClass of 2014
Brigham Young UniversityBS, Biophysics; Minor in Chemistry, 2006 - 2010
Certifications & Licensure
MT State Medical License 2022 - 2026
UT State Medical License 2020 - 2026
TN State Medical License 2018 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 24 citationsZyxin phosphorylation at serine 142 modulates the zyxin head–tail interaction to alter cell–cell adhesionS. Gregory Call, Jarom Y. Chung, John A. Davis, Braden D. Price, Tyler S. Primavera
Biochemical and Biophysical Research Communications. 2011-01-21 - 2 citationsHigh GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition.Anngela C Adams, Elizabeth S Borden, Anne M Macy, Nick Thomson, Haiyan Cui
Cancers. 2022-04-28 - 5 citationsMaintenance eculizumab dose adjustment in the treatment of atypical hemolytic uremic syndrome: a case report and review of the literature.Nick Thomson, Matthew L. Ulrickson
Clinical Case Reports. 2016-07-06
Journal Articles
- Adjuvant Therapy in Resected Melanoma, Letter to the Editor.Nick Thomson, MD, Rachel Doerr, NP, Michael G. Martin, MD, New England Journal of Medicine, 2018 Feb; 378(7):678-80.
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
